{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:50:31Z","timestamp":1787496631709,"version":"build-2736575974"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005357","name":"Slovak Research and Development Agency","doi-asserted-by":"crossref","award":["APVV-18-0084 - J.M.; APVV-22-0342"],"award-info":[{"award-number":["APVV-18-0084 - J.M.; APVV-22-0342"]}],"id":[{"id":"10.13039\/501100005357","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Grant Agency of the Ministry of Education, Research, Development and Youth of the Slovak Republic and Slovak Academy of Sciences","award":["VEGA-1\/0093\/22"],"award-info":[{"award-number":["VEGA-1\/0093\/22"]}]},{"name":"Scientific Grant Agency of the Ministry of Education, Research, Development and Youth of the Slovak Republic and Slovak Academy of Sciences","award":["VEGA-1\/0042\/24"],"award-info":[{"award-number":["VEGA-1\/0042\/24"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Despite developing new diagnostics, drugs, and vaccines, treating tuberculosis (TB) remains challenging. Monitoring inflammatory markers can contribute to more precise diagnostics of TB, identifying its active and latent forms, or monitoring its treatment success. We assessed alterations in plasma levels of 48 cytokines in 20 patients (17 males) with active pulmonary TB compared to age-matched healthy controls (n = 18). Blood samples were collected from individuals hospitalised with TB prior to commencing antibiotic therapy, after the first week, and following the third week. The majority of patients received treatment with a combination of four first-line antituberculosis drugs: rifampicin, isoniazid, ethambutol, and pyrazinamide. Plasmatic cytokine levels from patients three times and controls were analyzed using a Bio-Plex Pro Human Cytokine Screening Panel. The results showed significantly higher levels of 31 cytokines (p&lt;0.05) than healthy controls. Three-week therapy duration showed significantly decreased levels of nine cytokines: interferon alpha-2 (IFN-\u03b12), interleukin (IL) 1 alpha (IL-1\u03b1), IL-1 receptor antagonist (IL-1ra), IL-6, IL-10, IL-12 p40, IL-17, leukemia inhibitory factor (LIF), and tumor necrosis factor alpha (TNF-\u03b1). Out of these, only levels of IL-1\u03b1 and IL-6 remained significantly elevated compared to controls. Moreover, we have found a negative correlation of 18 cytokine levels with BMI of the patients but no correlation with age. Our results showed a clinical potential for monitoring the levels of specific inflammatory markers after a short treatment duration. The reduction in cytokine levels throughout the course of therapy could indicate treatment success but should be confirmed in studies with more individuals involved and a longer observation period.<\/jats:p>","DOI":"10.1371\/journal.pone.0305158","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T14:23:05Z","timestamp":1724941385000},"page":"e0305158","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring cytokine dynamics in tuberculosis: A comparative analysis of patients and controls with insights from three-week antituberculosis intervention"],"prefix":"10.1371","volume":"19","author":[{"given":"Michaela","family":"Krivo\u0161ov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-2830","authenticated-orcid":true,"given":"Mat\u00fa\u0161","family":"Doh\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"M\u00e4siarov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi\u00e1n","family":"Pr\u0161o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Gond\u00e1\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radovan","family":"Mur\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So\u0148a","family":"Fra\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Porvazn\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Solovi\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juraj","family":"Mokr\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"pone.0305158.ref001","author":"WHO","year":"2023","journal-title":"Global tuberculosis report 2023."},{"key":"pone.0305158.ref002","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.924410","article-title":"Improved Conventional and New Approaches in the Diagnosis of Tuberculosis.","volume":"13","author":"B Dong","year":"2022","journal-title":"Frontiers in Microbiology"},{"key":"pone.0305158.ref003","first-page":"11","article-title":"A Comprehensive Evaluation of GeneLEAD VIII DNA Platform Combined to Deeplex Myc-TB\u00ae Assay to Detect in 8 Days Drug Resistance to 13 Antituberculous Drugs and Transmission of Mycobacterium tuberculosis Complex Directly From Clinical Samples.","author":"I Bonnet","year":"2021","journal-title":"Frontiers in Cellular and Infection Microbiology."},{"key":"pone.0305158.ref004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev-med-040717-051502","article-title":"Molecular Diagnostics for Mycobacterium tuberculosis Infection","volume":"70","author":"KV Dicks","year":"2019","journal-title":"Annu Rev Med"},{"key":"pone.0305158.ref005","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.2147\/IDR.S381643","article-title":"Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis.","volume":"15","author":"L Nandlal","year":"2022","journal-title":"IDR"},{"key":"pone.0305158.ref006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40246-015-0033-3","article-title":"Success stories in genomic medicine from resource-limited countries","volume":"9","author":"K Mitropoulos","year":"2015","journal-title":"Hum Genomics"},{"key":"pone.0305158.ref007","doi-asserted-by":"crossref","first-page":"102169","DOI":"10.1016\/j.tube.2022.102169","article-title":"Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis","volume":"133","author":"R Jacobs","year":"2022","journal-title":"Tuberculosis"},{"key":"pone.0305158.ref008","article-title":"Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with Mycobacterium tuberculosis","volume":"14","author":"MS Shey","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"pone.0305158.ref009","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2147\/COPD.S364982","article-title":"Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation.","volume":"17","author":"I Barta","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"pone.0305158.ref010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12865-020-00381-w","article-title":"Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease","volume":"21","author":"E Guiedem","year":"2020","journal-title":"BMC Immunology"},{"key":"pone.0305158.ref011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tube.2018.08.011","article-title":"Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting","volume":"114","author":"V Clifford","year":"2019","journal-title":"Tuberculosis (Edinb)."},{"key":"pone.0305158.ref012","doi-asserted-by":"crossref","first-page":"100130","DOI":"10.1016\/j.crbiot.2023.100130","article-title":"Importance of IP-10 as a biomarker of host immune response: Critical perspective as a target for biosensing","volume":"5","author":"S Madhurantakam","year":"2023","journal-title":"Current Research in Biotechnology"},{"key":"pone.0305158.ref013","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41598-023-27895-8","article-title":"Cytokine upsurge among drug-resistant tuberculosis endorse the signatures of hyper inflammation and disease severity","volume":"13","author":"P Sampath","year":"2023","journal-title":"Sci Rep"},{"key":"pone.0305158.ref014","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","article-title":"Cytokines and Chemokines in Mycobacterium tuberculosis Infection.","volume":"4","author":"R Domingo-Gonzalez","year":"2016","journal-title":"Microbiol Spectr"},{"key":"pone.0305158.ref015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.641065","article-title":"Effect of Inflammatory Cytokines\/Chemokines on Pulmonary Tuberculosis Culture Conversion and Disease Severity in HIV-Infected and -Uninfected Individuals From South Africa.","volume":"12","author":"S Rambaran","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"pone.0305158.ref016","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s15010-022-01870-3","article-title":"Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients","volume":"51","author":"MM Vivekanandan","year":"2023","journal-title":"Infection"},{"key":"pone.0305158.ref017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5588\/ijtld.13.0243","article-title":"Diagnosis of paediatric tuberculosis using sputum induction in Botswana: programme description and findings","volume":"18","author":"DR Joel","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"pone.0305158.ref018","doi-asserted-by":"crossref","first-page":"653898","DOI":"10.3389\/fimmu.2021.653898","article-title":"Discovery and Validation of a Three-Cytokine Plasma Signature as a Biomarker for Diagnosis of Pediatric Tuberculosis.","volume":"12","author":"NP Kumar","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0305158.ref019","doi-asserted-by":"crossref","first-page":"854507","DOI":"10.1155\/2015\/854507","article-title":"Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and Biomarkers.","volume":"2015","author":"IV Lyadova","year":"2015","journal-title":"Mediators Inflamm."},{"key":"pone.0305158.ref020","doi-asserted-by":"crossref","first-page":"100343","DOI":"10.1016\/j.jctube.2022.100343","article-title":"Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries","volume":"29","author":"U Abbas","year":"2022","journal-title":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"},{"key":"pone.0305158.ref021","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/QAD.0000000000003523","article-title":"Latent tuberculosis is associated with heightened levels of pro-and anti-inflammatory cytokines among Kenyan men and women living with HIV on long-term antiretroviral therapy","volume":"37","author":"TM Temu","year":"2023","journal-title":"AIDS"},{"key":"pone.0305158.ref022","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1097\/MJT.0000000000000360","article-title":"The Impact of Treatment on the Serum Concentration of Interleukin-1 Beta in Pulmonary Tuberculosis.","volume":"24","author":"CA Anusiem","year":"2017","journal-title":"Am J Ther"},{"key":"pone.0305158.ref023","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/147323000403200313","article-title":"Change in serum concentrations of interleukin-2 and interferon-gamma during treatment of tuberculosis","volume":"32","author":"M Berktas","year":"2004","journal-title":"J Int Med Res"},{"key":"pone.0305158.ref024","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1155\/MI.2005.256","article-title":"Changes in Serum Cytokine Levels in Active Tuberculosis With Treatment.","volume":"2005","author":"F Deveci","year":"2005","journal-title":"Mediators Inflamm"},{"key":"pone.0305158.ref025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jprot.2016.06.016","article-title":"Serum inflammatory profiles in pulmonary tuberculosis and their association with treatment response","volume":"149","author":"R Choi","year":"2016","journal-title":"J Proteomics"},{"key":"pone.0305158.ref026","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2014.06.002","article-title":"Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy","volume":"62","author":"IH Chowdhury","year":"2014","journal-title":"Molecular Immunology"},{"key":"pone.0305158.ref027","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tube.2015.04.011","article-title":"Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis","volume":"95","author":"A Jayakumar","year":"2015","journal-title":"Tuberculosis (Edinb)."},{"key":"pone.0305158.ref028","doi-asserted-by":"crossref","first-page":"e36886","DOI":"10.1371\/journal.pone.0036886","article-title":"Effect of Standard Tuberculosis Treatment on Plasma Cytokine Levels in Patients with Active Pulmonary Tuberculosis.","volume":"7","author":"C Riou","year":"2012","journal-title":"PLOS ONE"},{"key":"pone.0305158.ref029","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2249.1999.00783.x","article-title":"Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment.","volume":"115","author":"A Verbon","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"pone.0305158.ref030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cytogfr.2010.10.004","article-title":"IL-17 and Th17 cells in tuberculosis","volume":"21","author":"E Torrado","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"pone.0305158.ref031","first-page":"100028","article-title":"Value of serum cytokine biomarkers TNF-\u03b1, IL-4, sIL-2R and IFN-\u03b3 for use in monitoring bacterial load and anti-tuberculosis treatment progress.","volume":"2","author":"W Nie","year":"2020","journal-title":"Cytokine: X."},{"key":"pone.0305158.ref032","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/j.ijid.2009.06.022","article-title":"Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease","volume":"14","author":"P. M\u00e9ndez-Samperio","year":"2010","journal-title":"International Journal of Infectious Diseases"},{"key":"pone.0305158.ref033","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.4049\/jimmunol.174.7.4185","article-title":"Maintenance of pulmonary Th1 effector function in chronic tuberculosis requires persistent IL-12 production","volume":"174","author":"CG Feng","year":"2005","journal-title":"J Immunol"},{"key":"pone.0305158.ref034","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.168.3.1322","article-title":"Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present","volume":"168","author":"AM Cooper","year":"2002","journal-title":"J Immunol"},{"key":"pone.0305158.ref035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.897193","article-title":"Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses.","volume":"13","author":"A Llibre","year":"2022","journal-title":"Frontiers in Immunology."},{"key":"pone.0305158.ref036","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","article-title":"Cytokines and Chemokines in Mycobacterium tuberculosis infection","volume":"4","author":"R Domingo-Gonzalez","year":"2016","journal-title":"Microbiol Spectr"},{"key":"pone.0305158.ref037","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"CA Dinarello","year":"2011","journal-title":"Blood"},{"key":"pone.0305158.ref038","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jinf.2017.04.011","article-title":"Mycobacteria-specific cytokine responses as correlates of treatment response in active and latent tuberculosis","volume":"75","author":"V Clifford","year":"2017","journal-title":"J Infect"},{"key":"pone.0305158.ref039","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12879-020-05047-x","article-title":"Serum level of IL-1ra was associated with the treatment of latent tuberculosis infection in a Chinese population","volume":"20","author":"H Zhang","year":"2020","journal-title":"BMC Infectious Diseases"},{"key":"pone.0305158.ref040","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.4049\/jimmunol.181.8.5545","article-title":"Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA\/J Mice","volume":"181","author":"GL Beamer","year":"2008","journal-title":"J Immunol"},{"key":"pone.0305158.ref041","first-page":"79","article-title":"Immunomodulatory Effects of Levofloxacin on Patients with Pneumonia in Assiut University Hospitals.","volume":"22","author":"MS Badari","year":"2015","journal-title":"Egypt J Immunol"},{"key":"pone.0305158.ref042","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","article-title":"Immunomodulatory effects of quinolones","volume":"3","author":"A Dalhoff","year":"2003","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0305158.ref043","doi-asserted-by":"crossref","first-page":"e0192664","DOI":"10.1371\/journal.pone.0192664","article-title":"Identification of plasma biomarkers for discrimination between tuberculosis infection\/disease and pulmonary non tuberculosis disease","volume":"13","author":"MP La Manna","year":"2018","journal-title":"PLoS One"},{"key":"pone.0305158.ref044","doi-asserted-by":"crossref","first-page":"100043","DOI":"10.1016\/j.medidd.2020.100043","article-title":"COVID-19 lockdown: de-risking exit by protecting the lung with leukaemia inhibitory factor (LIF).","volume":"6","author":"SM Metcalfe","year":"2020","journal-title":"Med Drug Discov."},{"key":"pone.0305158.ref045","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20180325","article-title":"Type I interferons in tuberculosis: Foe and occasionally friend","volume":"215","author":"L Moreira-Teixeira","year":"2018","journal-title":"J Exp Med"},{"key":"pone.0305158.ref046","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1371\/journal.pmed.0040115","article-title":"Malnutrition and Infection: Complex Mechanisms and Global Impacts.","volume":"4","author":"UE Schaible","year":"2007","journal-title":"PLOS Medicine."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T14:23:43Z","timestamp":1724941423000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0305158"}},"subtitle":[],"editor":[{"given":"Rizaldy Taslim","family":"Pinzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0305158","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}